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Abstract Despite the very good results of anterior cer-
vical discectomy and fusion, there are concerns of adjacent
level degeneration. For this reason, interest has grown in
the potential for motion sparing alternatives. Cervical disc
arthroplasty is thus evolving as a potential alternative to
fusion. Speciﬁc design characteristic and implants will be
reviewed and outcomes summarized.
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Introduction
Anterior cervical discectomy and fusion (ACDF) for
degenerative disc disease has been widely performed since
the initial description of the procedure in the late 1950s [1].
The procedure has been used to address degenerative
changes and neural element compression with favorable
rates of fusion and successful clinical outcomes in 85–95%
of the patients [2, 3] (Fig. 1).
In the cervical spine with disc herniation or spondylosis
causing radiculopathy and/or myelopathy, the decision of
performing an anterior decompression is independent of
the type of reconstruction that will follow. After the
decompression is accomplished, a reconstruction is per-
formed to avoid postoperative pain and kyphosis. This
reconstruction has typically been with a fusion but total
disc replacement (TDR) is evolving as a potential alter-
native [4] (Figs. 2 and 3).
Rationale of cervical arthroplasty
Adjacent segment degeneration
Fusion of a mobile spinal segment may lead to adverse
effects such as accelerated degeneration of the adjacent
motion segment [5]. Biomechanical studies have shown
that cervical fusion alters the adjacent level kinematics [6].
It has been demonstrated that after an ACDF, the loss of
motion at the fused level is compensated by an increase in
motion [7] as well as an increase in intradiscal pressure at
adjacent levels [8].
Adjacent segment degeneration (ASD) is deﬁned as
radiographic changes at a segment adjacent to a fusion and
is not necessarily associated with symptoms. Adjacent
level disease, as opposed to simple degeneration, may be
associated with pain, radicular, or myelopathic signs and/or
symptoms [2].
Hilibrand et al. [9] reported the incidence of symptom-
atic ASD to be 2.9% per year after ACDF in an often
quoted study. Survivorship analysis projected that a 25.6%
of the patients who underwent an ACDF would develop
symptomatic ASD within 10 years after. The incidence of
ASD was higher at the C5-6 and C6-7 levels. However, of
note, this study did ﬁnd that longer constructs did have a
lesser incidence of adjacent level degenerative changes and
raised the question of weather the affect was due to
increased loads of the adjacent level or the progression of
the natural history of degenerative disc disease. Gofﬁn
et al. [10] also showed a 92% incidence of radiographic
ASD 5-year follow-up after ACDF. The re-operation rate
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time conservative therapy was 6.11%. Overall, cervical
studies do suggest that there is load concentration and
degeneration adjacent to a fusion.
Alternatively, it has been argued that the relatively high
frequency of ASD and additional surgery may actually
reﬂect the natural history of cervical spondylosis. We do
know that after age 40 almost 60% of the population will
have radiographic evidence of degenerative changes, and
after age 65 95% of men and 70% of women have radio-
graphic evidence of degenerative changes [4]. To that
point, patients followed after posterior laminoforaminoto-
my (without fusion) have been shown to have an incidence
of ASD of 3.9% per year [11]. This is in the range of that
described for ACDF in a population without fusion and
thus for whom there would not be expected increased
loading at the adjacent levels.
In response to the question of ASD as a result of the
natural history of cervical spondylosis, Gofﬁn et al. [12]
studied the development of radiological ASD in patients
who underwent fusion with anterior plating for trauma.
Over a mean follow-up of 7 years, 60% of patients who
had undergone fusion had radiographic evidence of ASD.
None of these changes manifested clinically with radicu-
lopathy or myelopathy and thus were not treated surgically.
In another study, Gofﬁn et al. [10] showed a 92% inci-
dence of radiologic ASD at 5-year follow-up after ACDF
for cervical spondylosis and trauma patients. The increase
in degeneration was statistically equally distributed among
younger trauma cases and older non-trauma cases operated
mainly for disc herniation or spondylosis. This argues back
to the point that symptomatic ASD may be accelerated by
fusion procedures.
Potential role of cervical disc arthroplasty
Although there is some conﬂicting evidence regarding the
incidence of symptomatic ASD, cervical disc arthroplasty
has been advocated as a potential alternative to fusion to
avoid this potential complication [13]. Normal motion
between two vertebrae occurs around a point described as
instantaneous axis of rotation (IAR). The location of the
Fig. 2 Lateral cervical
radiograph (a) of a patient with
a disc herniation at the C67
level. Prodisc-C was performed
and lateral (b), ﬂexion (c), and
extension ﬁlms (d) are shown
Fig. 3 Lateral cervical
radiograph with degenerative
changes at CC56 and C67 (a).
Two-level discovery
arthroplasty was performed and
postoperative lateral (b), ﬂexion
(c), and extension (d) ﬁlms are
shown
Fig. 1 Lateral cervical radiograph of a patient with multilevel
spondylosis (a) for which an ACDF was performed at C56 and C67
for radicular symptoms (b)
Curr Rev Musculoskelet Med (2008) 1:124–130 125IAR varies between levels but it is generally located in the
posterior half of the upper portion of the inferior vertebral
body. In order to protect the facet joints from abnormal
stresses, cervical arthroplasty devices should have an axis
of rotation that mimics the kinematics of the normal spine.
They should also restore physiologic range of motion, be
able to restore disc height, and transmit axial loading forces
from the superior vertebral body to the one inferior [14].
Biomechanical studies have suggested that TDR may
allow for a more normal restoration of load transfer and
kinematics at adjacent levels when compared with fusion
[7]. After TDR, the stress proﬁles in specimens at the
adjacent level discs were similar to those of intact, non-
treated levels, with reduced stresses in the adjacent level
annulus when compared with spines with simulated fusions
[15].
Robertson et al. [16] conducted a study to compare
the incidence of radiological documented changes and
symptomatic adjacent-level cervical disc disease after
single-level discectomy and subsequent cervical fusion or
arthroplasty using the Bryan disc. This study showed the
appearance of new radiographic changes in 34.6% of the
fusion-treated patients and in 17.5% of the arthroplasty-
treated patients at 24 months (P = 0.009). New symp-
tomatic adjacent degenerative disc disease occurred in
7% of the fusion group and in none of the arthroplasty
group (P = 0.018). This study showed that maintaining
motion with arthroplasty after single-level anterior disc-
ectomy rather than fusion will delay or prevent
symptomatic postoperative disc disease and will decrease
to a signiﬁcant degree the associated radiological disc
degeneration [16].
Treatment of symptomatic ASD
The management of symptomatic ASD that requires sur-
gical intervention is more challenging than primary
pathology. The surgical risks such as dysphagia and
pseudoarthrosis are increased as compared to index surgi-
cal procedures [17]. To some extent, this is due to the need
to re-approach the anterior cervical region (something that
may be done from the same or opposite side). Additionally,
the biomechanics of being adjacent to an already fused
level increases the mechanical loads at an adjacent level
site. Moreover, the success rate of ACDF decreases with an
increase in the number of levels fused [17].
Because the success of cervical TDR does not rely on a
biological fusion process, it may be a more effective
treatment strategy for ASD [18]. In fact, there is an evi-
dence of good results in patients with symptomatic ASD
after ACDF or congenital fusion treated with arthroplasty
[19]. Furthermore, TDR has the patient appeal of not
beginning a gradual adding on fusion process.
Decrease of morbidity associated with ACDF and
potentially hastened recovery
There are certainly potential morbidities associated with
any surgical intervention. ACDF has long been associated
with the morbidity of bone graft harvest, including pain,
infection, meralgia paresthetica, and pelvic fracture [18,
20]. This has largely decreased as other bone graft mate-
rials such as allograft, cages, etc., have become more
standard, especially for short constructs.
There is additionally the potential of pseudoarthrosis
with fusion procedures. This may not be symptomatic even
if it occurs, but motion and potential collapse may be
associated with axial pain or neural symptoms which may
require further attention.
Further, many surgeons place patients in external
immobilization collars after ACDF. This is not well sup-
ported by the literature in an era where most are using
anterior cervical instrumentation, but this is cited as a
signiﬁcant issue by many patients. With TDR, the duration
of postoperative immobilization is decreased, which facil-
itates a faster return to daily activities [20]. To this end,
Mummaneni et al. [21] showed that patients who under-
went cervical TDR returned to work 16 days sooner than
those who underwent ACDF.
Indications and contraindications for cervical TDA
The quoted indications for cervical TDA are largely drawn
from the clinical trials that have been used to assess their
safety and efﬁcacy. Within trials, there must be ‘‘on label’’
uses for the devices only. However, as cervical arthroplasty
devices become available as approved devices, the indi-
cations for which they are considered continue to expand.
Most disc arthroplasty devices have ‘‘on label’’ indica-
tions for patients with degenerative disc disease who have
failed conservative treatment and require surgical inter-
vention at one or two levels from C3 to T1 for symptoms
and signs of radiculopathy or myelopathy with or without
axial neck pain secondary to disc herniation or spondylosis
[18, 22].
Sekhon [23] reported a series of 11 patients and 15
artiﬁcial disc prostheses studying Bryan cervical disc for
the treatment of cervical spondylotic myelopathy. He
reported that 91% of patients had a good or excellent
outcome using Odom’s criteria and a statistically signiﬁ-
cant decrease in Nurick myelopathy scores at a mean
follow-up of 18 months.
Wang et al. [24] reported a series of patients with cer-
vical spondylotic myelopathy using the Bryan disc
prosthesis. All of the 65 patients (77 levels) with at least
12 months of follow-up showed improvement according to
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average JOA score of the 65 patients increased from 8.7 to
15.5 at last follow-up.
Alternative indications for arthroplasty may be consid-
ered. For example, three or more levels with degenerative
disc disease and the treatment of symptomatic ASD after a
fusion may be appropriately considered for TDA [18]. A
study reported by Pimenta et al. [25] investigating multi-
level cervical arthroplasty versus single-level cervical
arthroplasty using the porous-coated motion (PCM) pros-
thesis showed signiﬁcantly improved clinical outcomes for
multilevel TDR compared to single-level TDR.
Conditions generally agreed to be contraindications for
this procedure include: instability on dynamic radiographs,
facet arthropathy, osteoporosis, infection, prior laminec-
tomy, primarily axial neck pain, rheumatoid arthritis,
ankylosing spondylitis, ossiﬁcation of the posterior longi-
tudinal ligament (PLL), and diffuse idiopathic skeletal
hyperostosis [3, 18, 22]. Multi-level cervical disc arthro-
plasty has not been evaluated prospectively and appropriate
bone density values should be ensured pre-operatively.
Careful CT scan assessment of facet joints should be per-
formed to exclude patients with facet degeneration of
clinical signiﬁcance.
Surgical considerations for cervical TDA
Many surgeons are familiar with ACDF procedures.
However, there are speciﬁc surgical considerations which
must be given to cervical TDA in making the transition
from one procedure to the other.
For example, a complete discectomy is needed with
complete removal of all osteophytes. As there will continue
to be motion, one must be certain to avoid the potential of
dynamic compression in the foramen which is not a con-
sideration with ACDF. Further, there has long been the
concept that residual osteophytes will resorb after a fusion
and this will not be the case after TDA.
Most believe that the PLL should be removed with TDA
even though this is not always done with ACDF. Not only
does this ensure that a complete decompression has been
achieved, but also the resection of the PLL ensures that the
disc space has been mobilized and facilitates parallel dis-
traction, restoration of the intervertebral height, and
mobility of the segment.
Although the cartilaginous endplate is removed for
TDA, the bony endplate is preserved as possible to mini-
mize the risk of implant subsidence. The vertebral
endplates should be burred until there are two parallel
surfaces to facilitate even the insertion of the device and to
allow appropriate surface contact between the endplates
and the device.
With implantation of a cervical TDA, proper midline
identiﬁcation and placement of the device is critical. This is
in sharp distinction to a graft for ACDF which can be
placed eccentrically or a cervical TDA will not function as
designed and allow restoration of motion. We therefore
advocate careful ﬂuoroscopic evaluation to ensure that
proper visualization of the index disc space can be
achieved. If due to body habitus it is not possible to clearly
visualize the interspace, strong consideration for fusion
should be made.
Finally, after the implantation of the device, over-dis-
traction of the interbody space should be avoided since it
may lead to nerve root stretch, facet joint overload, and/or
loss of motion [26–28].
Design considerations
The Cervical Spine Study Group developed a new
nomenclature system for cervical arthroplasty. Currently,
cervical arthroplasty devices can be classiﬁed as non-
articulating, uniarticulating, or biarticulating. The devices
are either modular (meaning that they have replaceable
components) or they are non-modular (meaning that they
have non-replaceable components) [29].
Devices are considered constrained in certain planes if
they restrict motion to less than that seen physiologically.
Devices are considered semi-constrained in certain planes
if they allow motion similar to that seen physiologically.
Devices are considered non-constrained in certain planes of
motion if there is no mechanical stop to the motion and are
reliant on the perispinal soft tissue, and the inherent com-
pression across the disc space to provide restraint to
extremes of motion [5]. Some devices have inherent cou-
pling of motion in different planes, whereas others do not.
Prostheses are made of several components, each of
which has speciﬁc functional considerations which are
affected by material, design, articulation, etc. Components
must remain permanently afﬁxed to the vertebral endplate
and wear characteristics must be optimized [4].
Implant endplates must be made of durable, non-reac-
tive metals that can be molded to the desired form. Cobalt–
chrome is commonly considered as biocompatible with
advantageous mechanical properties. However, this does
signiﬁcantly interfere with potential future imaging studies
such as CT and MRI [14, 30]. Stainless steel is similarly
biocompatible and less expensive to fabricate but has a
high modulus of elasticity which may be related to subsi-
dence. Titanium is the other biocompatible material which
is often considered as it has a modulus of elasticity most
similar to bone and advantageous to future MRI imaging
[4, 31]; however, this is more susceptible to notching and
wear. Surface treatment of titanium, such as coating with
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wear characteristics [4].
The distribution of force and subsidence is possibly the
most important biomechanical considerations for an artiﬁ-
cial disc. The idea is to distribute the forces involved as
uniformly as possible over a large area [30]. The interface
between prosthesis and vertebra should allow transmission
of axial forces between adjacent vertebrae [14].
The initial stability of the prosthesis may be accom-
plished by some form of anchoring of the implant to the
vertebral body by screws, ﬁns, or keels. Long-term stability
typically implies osteointegration of the device into sur-
rounding bone. Implant surface coatings to encourage bone
ingrowth include titanium wire mesh, plasma-sprayed
titanium, porous cobalt–chrome, and bioactive materials
such as hydroxyapatite and calcium phosphate. Initial and
long-term ﬁxations should prevent subluxation, subsidence,
or displacement [4, 14].
The articular surfaces are the other very important design
consideration for any arthroplasty device. Most commonly
this has been metal on polymer such ultra-high molecular
weightpolyethylene(UHMWPE)orpolyurethane[14].This
articulation provides a low-friction articulation. There has
beensigniﬁcantconcernofresultantpolyethylenedebris,but
this has not been found to be a signiﬁcant clinical problem.
Alternatively, metal-on-metal or ceramic articulation may
be considered. These have potentially lower wear rates
compared with polyethylene-on-metal articulations but
provide less shock absorption [4].
Speciﬁc implants
Metal-on-metal devices
The Prestige ST cervical disc (Medtronic Sofamor Danek)
is a stainless steel on stainless steel device consists of two
articulating components in a ball-and-trough articulation. It
was approved by the FDA on July 2007. It is attached to
the cervical vertebrae with screws. The design of the
device provides relatively unconstrained motion. The sur-
faces of the device contacting the endplates are grit-blasted
to promote bone osteointegration [26]. The Prestige LP is
the most recent version of the Prestige family of cervical
discs. It radically differs from its predecessors in that acute
ﬁxation is achieved by a set of rails that are placed on the
intervertebral contact surface. It is manufactured from a
titanium ceramic composite material, and a porous titanium
plasma spray coating on the endplate surface facilitates
bone in-growth and long-term ﬁxation [26, 29, 32].
The CerviCore cervical disc (Striker Spine) is con-
structed of chrome–cobalt design with a saddle-shaped
articulation. The device is attached to vertebral bodies by
screws. The base plates feature a titanium spray and three
spikes. The designers assert that the device mimics the
normal disc axis of rotation and the function of the unco-
vertebral articulation and promotes vertebral foraminal
widening during coupled rotation and bending. There are
no reports of clinical implantation of this device [4].
Metal-on-polymer devices
The ProDisc-C cervical disc (Synthes Spine Solutions) was
approved by the FDA on December 2007. It consists of
cobalt–chromium alloy endplates with a central keel for
anchorage to the vertebral bodies and a locking core of
UHMWPE as a central polymer that provides a ball-and-
socket articulation. The endplates are coated with a tita-
nium plasmapore for tissue compatibility and bone in-
growth. It is considered constrained in compression,
unconstrained in distraction and rotation, and semi-con-
strained in ﬂexion, extension, and lateral bending [27, 33].
The Bryan cervical disc (Medtronic Sofamor Danek)
was designated to preserve normal kinematics with an
axially symmetric prosthesis that mimics normal ﬂexion,
extension, and lateral bending. It consists of a single-piece
of a porous-coated, clamshell-shaped titanium endplates
with a polycarbonate polyurethane core. A polyurethane
membrane that surrounds the articulation reduces friction
and contains debris [20]. The device provides a relatively
unconstrained range of motion [28].
The PCM prosthesis (Cervitech) has a large-radius
UHMWPE core with cobalt–chrome endplates which are
coated with titanium with electrochemically coated cal-
cium phosphate that encourages bone integration. The low-
proﬁle PCM prosthesis is used when the PLL is preserved.
In cases when the PLL have been removed as part of the
decompression, the ﬁxed PCM implant is preferred. The
ﬁxed implant incorporates anterior ﬂanges and screws for a
better stability [4, 20].
Secure
-C Cervical Artiﬁcial Disc (Globus Medical)
consistsofacentralUHMWPEcomponentandtwotitanium
plasma-sprayed cobalt–chromium–molybdenum alloy end-
plates. It is considered a semi-constrained device. The
porous-coatedbone-contactingsurfacespromoteosseousin-
growth. The moving axis of rotation allows for shear trans-
lation. The device is under the IDE granted by the FDA.
Other devices include CerPass (NuVasive), a ceramic-
on-ceramic prosthesis; NeoDisc (NuVasive), comprised of
a solid silicone core surrounded by a digitally embroidered
polyester jacket that is attached to the vertebral bodies with
titanium alloy screws; Mobi-C (LDR Me ´dical), comprised
of two metal spinal plates and an UHMWPE mobile insert;
Kineﬂex-C (Spinal Motion), a metal-on-metal prosthesis;
Discover (DePuy Spine), a metal-on-polymer device; Dis-
cocerv (Scient’x), comprised of titanium alloy endplates
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(SeaSpine), a ceramic-on-ceramic prothesis; Rescue (Bio-
met/EBI), a pyrocarbon-on-pyrocarbon prosthesis; Physio-
C (Nexgen Spine), a non-articulating metal-polymer pros-
thesis; Cervidisc (Scient’x), a ceramic-on-ceramic
prosthesis; SaluDisc (SpineMedica), a non-articulating
hydrogel prosthesis; CMP (Vertebron), a metal-on-poly-
ethylene-on metal prosthesis [34].
Clinical outcomes
One- and two-year clinical outcome data indicate that
cervical TDR is at least as effective as standard ACDF [35–
42]. Mummaneni et al. [21] reported the results of a pro-
spective randomized multi-center study in which the results
of cervical disc arthroplasty using the Prestige ST were
compared with ACDF in patients treated for symptomatic
single-level cervical degenerative disc disease. They found
that the device maintained physiological segmental motion
at 24 months after implantation. At last follow-up, all
treated levels were mobile with a mean ﬂexion–extension
difference of 7.59. The investigational group showed
improved neurological success, improved clinical out-
comes, and a reduced rate of secondary surgeries compared
with ACDF.
Sasso et al. [43] reported the results of a prospective,
randomized, controlled, multi-center trial with 24-month
follow-up comparing the outcomes of cervical arthroplasty
using the Bryan cervical disc prosthesis to ACDF for
patients with single-level symptomatic cervical radiculop-
athy or myelopathy refractory to non-operative
interventions. They found that the investigational group
had statistically signiﬁcant improvements as assessed by
the Neck Disability Index, the Neck Pain Score, and the
SF-36 Physical component scores. Arm pain relief was
similar in both the investigational and the control groups.
The disc replacement group retained an average of 7.0 of
angular motion at the target level at 24 months.
Other studies have reported a signiﬁcant improvement in
pain and functional outcome in patients treated with dis-
tinct TDR prostheses at 12–18 months [44–46] and 4 years
of follow-up with preservation of motion and without
development of ASD [47].
Extended follow-up studies with larger patient popula-
tions are required to evaluate the efﬁcacy, safety, and
ability to prevent the ASD of cervical TDR.
Complications
Few early complications have been reported after cervical
TDR [14]. Pickett et al. [48] reported on the complications
in patients treated with Bryan prosthesis. They implanted
96 discs in 74 patients and found a perioperative compli-
cation rate of 6.2% per treated level. The rate of late-onset
complications was 5.2% per treated level and includes two
cases of heterotopic ossiﬁcation, one prosthesis migration,
one reoperation for severe segmental kyphosis, and one
failure of the prosthesis in extension. Segmental motion
was preserved in 96% or the cases.
Accelerated wear and particle debris formation leading
to loosening of the device does not appear to be an issue
[14]. Wear testing indicates that these devices will have a
long life once implanted [49]. Long-term evaluation is
needed to evaluate this statement.
No cases of subsidence of cervical arthroplasty devices
have been reported to date [18].
Future directions
It is expected that motion preservation after cervical TDR
will decrease the incidence of ASD. Longer-term follow-up
studies are needed to assess this issue. Other points to be
considered are the percentage of spontaneous fusion over
time, the limitations in restoring abnormal curves, and the
cost of the prostheses.
As experience is increased, additional potential indica-
tions may emerge such as neck pain, deformity correction,
or revision of previous fusion [3].
The continuing research in cervical spine biomechanics,
biomaterial science, and surgical technique will probably
offer in the future alternative prosthesis with better designs
for cervical arthroplasty.
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